Ketamine Treatment Plans for Chronic Conditions
RecruitingNCT06038409
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
Study details
- Official title
- Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions
- Conditions
- Chronic Pain
- Depressive Disorder
- Anxiety Disorders
- Chronic Disease
- Interventions
- Sponsor
- RIVER Foundation
- Start date
- 2023-01-01
- Primary completion
- 2029-01-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Must have an identifiable chronic condition. Exclusion Criteria: Healthy population
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06038409